(2-Methoxypyridin-4-yl)boronic acid → 4-[5-(2-Methoxy-pyridin-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-ylamino]-N-pyridin-3-ylmethyl-benzamide

HRID 1784008Notes

Reaction equation

HRID 1784008 reaction equation
C[N:2]1CCN(C2C=CC(NC3C4N(N=CN=4)C(C4C=C(C(N)=O)SC=4)=CN=3)=CC=2)CC1.Br[C:33]1[N:38]2[N:39]=[CH:40][N:41]=[C:37]2[C:36]([NH:42][C:43]2[CH:58]=[CH:57][C:46]([C:47]([NH:49][CH2:50][C:51]3[CH:52]=[N:53][CH:54]=[CH:55][CH:56]=3)=[O:48])=[CH:45][CH:44]=2)=[N:35][CH:34]=1.[CH3:59][O:60][C:61]1[CH:66]=[C:65](B(O)O)[CH:64]=[CH:63][N:62]=1>C([O-])([O-])=O.[K+].[K+].O1CCOCC1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[NH3:2].[CH3:59][O:60][C:61]1[CH:66]=[C:65]([C:33]2[N:38]3[N:39]=[CH:40][N:41]=[C:37]3[C:36]([NH:42][C:43]3[CH:58]=[CH:57][C:46]([C:47]([NH:49][CH2:50][C:51]4[CH:52]=[N:53][CH:54]=[CH:55][CH:56]=4)=[O:48])=[CH:45][CH:44]=3)=[N:35][CH:34]=2)[CH:64]=[CH:63][N:62]=1

Participants

8

Procedure

This compound may be prepared using methods as described for Compound 6, step 4 using 4-(5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-ylamino)-N-pyridin-3-ylmethyl-benzamide (120 mg, 0.28 mmol), 2-methoxypyridine-4-boronic acid (87 mg, 0.57 mmol) and Pd(PPh3)4 (81 mg, 0.07 mmol) in 1.5M K2CO3 (aq) (1.6 mL) and dioxane (2.9 mL). The crude material is purified by silica gel column chromatography eluting with DCM followed by 99:1 then 97:3 then 95:5 DCM:NH3 (7M in MeOH) to afford the title compound as a white solid (92.6 mg, 73%).

Workup

  1. customThis compound may be prepared
  2. customThe crude material is purified by silica gel column chromatography
  3. washeluting with DCM

Sources & evidence

ORD record
ord-21b1c2adf0644a34b21ca76c607e94a5
Source dataset
uspto-grants-2009_03
Patent number
US07501411B2

Reaction notes

Loading…